Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced new dermatology data presented at the European Academy of Dermatology and Venereology (EADV) ...
Are finding profitable stocks and making money in today's market becoming more difficult? Sahil Kapoor, Market Strategist & Head – Products at DSP Mutual Fund, agrees that finding bargains is ...
Switching between adalimumab and adalimumab-fkjp in Phase 3 study in patients with chronic plaque psoriasis supports interchangeability between adalimumab and adalimumab-fkjpBiosimilarity between ...